Moreover, immunofluorescent staining of ceritinib-treated tumors displayed a significantly reduced number of Ki67-positive proliferating cells compared to the vehicle-treated tumor tissue (Fig. 5J). This evidence concerns the gene MKI67 and neoplasm.